Who is sponsoring NCT02337881?

NCT02337881 is sponsored by Al Hayat National Hospital.

What drugs are being tested in NCT02337881?

Interventions in NCT02337881: nifedipen, Sildenafil.

What condition does NCT02337881 study?

NCT02337881 studies Labor Preterm Requiring Hospitalization.

Is NCT02337881 still recruiting?

NCT02337881 is currently status unknown. Last updated 21 June 2016.

Last reviewed 2016-06-21 · How we verify

NCT02337881

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Combined Nifedipine and Sildenafil Citrate Versus Nifedipine Alone in Acute Tocolysis of Preterm Labor: A Randomized Clinical Trial

Status unknown Phase 1 Last updated 21 June 2016

What this trial tests

Phase 1 trial testing nifedipen in Labor Preterm Requiring Hospitalization in 227 participants. Status unknown.

Timeline

1 January 2015

Primary endpoint
1 October 2016

1 October 2016

Quick facts

Lead sponsor	Al Hayat National Hospital
Phase	Phase 1
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	prevention
Enrollment	227
Start date	1 January 2015
Primary completion	1 October 2016
Estimated completion	1 October 2016
Sites	2 locations across Egypt, Saudi Arabia

Drugs / interventions tested

nifedipen — full drug profile →
Sildenafil (sildenafil) — full drug profile →

Conditions studied

Labor Preterm Requiring Hospitalization — all drugs for Labor Preterm Requiring Hospitalization →

Sponsor

Al Hayat National Hospital

Who can join

Eligibility, female only, with Labor Preterm Requiring Hospitalization. Healthy volunteers can join.

What's being measured

Primary outcomes are the specific endpoints the trial is designed to prove or disprove.

the proportion of women remaining undelivered during the whole period of hospitalization. Treatment failure is considered in participants who delivered during this period, or those who need repeated treatment course.
Time frame: 9 months

Sponsor's own description

The aim of this study is to assess whether or not the emergency tocolytic effect of combined nifedipine and sildenafil citrate will have a superior effect over nifedipine alone in terms of inhibiting eminent preterm labor and improving perinatal outcomes.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT02337881 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Al Hayat National Hospital
Last refreshed: 21 June 2016

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02337881.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing